Ge. Theodoropoulos et al., SIGNIFICANCE OF ESTROGEN-RECEPTORS AND CATHEPSIN-D TISSUE DETECTION IN GASTRIC ADENOCARCINOMA, Journal of surgical oncology, 58(3), 1995, pp. 176-183
Estrogen receptors (ERs) have recently been reported to be present in
carcinomas of stomach, an organ that has so far been considered as non
target for sex hormones. Cathepsin D is an estrogen-regulated lysosoma
l protease that has been overexpressed in breast cancer. ER and cathep
sin D immunohistochemical expression were studied in this research in
order to estimate their association to known histopathological and cli
nical parameters and their possible prognostic significance as well. S
ixty-two patients with gastric adenocarcinomas were included in this s
tudy. The cancers were studied immunohistochemically concerning ER pos
itivity in tumor cell nuclei and cathepsin D cytoplasmic expression. N
uclear ER staining was detected in tumor cells of 25% of male and 27%
of female patients. ER positivity was demonstrated mainly in the well
and moderately differentiated carcinomas; 87.5% of ER(+) tumors were a
lso characterized as cathepsin D positive and a significant correlatio
n between ER and cathepsin D positive expression was demonstrated (P <
0.05). Cytoplasmic cathepsin D expression was observed in carcinomato
us cells of 70.9% of gastric tumors. Early tumor stage and good differ
entiation were significantly associated with increased cathepsin D exp
ression (P < 0.05, P < 0.001). Histologic type, degree of differentiat
ion and tumor stage were significantly correlated to survival (P < 0.0
5, P < 0.001 and P < 0.001). The patients who were cathepsin D(+) had
a significant prognostic advantage over the cathepsin D(-) patients (P
< 0.001). The presence of ER and estrogen-regulated cathepsin D indic
ates the involvement of sex hormonal factors in these tumors and cathe
psin D positive expression in tumor cells seems to be related to bette
r prognosis. Their biological, clinical, and prognostic roles remain t
o be further elucidated. (C) 1995 Wiley-Liss, Inc.